BMRN vs XRX · P/E 40, rev $1.76B vs rev $1.92B
Biomarin Pharmaceutical Inc (BMRN) versus Xerox Corp (XRX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Xerox Corp (XRX) is a business equipment & supplies company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported XRX revenue for 2026-06-30 was $1.92B. Net income was $13.0M. Revenue was up 4.1% from 2026-03-31 to 2026-06-30. XRX currently screens at market cap $410.6M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. XRX currently screens at market cap $410.6M.
Not investment advice. Open the BMRN and XRX stock pages for the full models.
Not investment advice.